Cost-Effectiveness Of Adjuvant Olaparib For Patients With Germline Brca1/2-Mutated, High- Risk, Human Epidermal Growth Factor-2-Negative Breast Cancer In Portugal

AuthID
 P-018-42Y
5
Author(s)
Andrade, A
·
Cortesao, S
·
Dias, A
·
Tavares, AL
Document Type
Abstract
Year published
2024
Published
in VALUE IN HEALTH, ISSN: 1098-3015
Volume: 27, Issue: 12
Indexing
Wos®
Publication Identifiers
Wos: WOS:001414964800231
Source Identifiers
ISSN: 1098-3015
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service